AMPK as a Therapeutic Target for Treating Metabolic Diseases
- PMID: 28647324
- DOI: 10.1016/j.tem.2017.05.004
AMPK as a Therapeutic Target for Treating Metabolic Diseases
Abstract
The AMP-activated protein kinase (AMPK) is a central regulator of multiple metabolic pathways and may have therapeutic importance for treating obesity, insulin resistance, type 2 diabetes (T2D), non-alcoholic fatty liver disease (NAFLD), and cardiovascular disease (CVD). Given the ubiquitous expression of AMPK, it has been a challenge to evaluate which tissue types may be most beneficially poised for mediating the positive metabolic effects of AMPK-centered treatments. In this review we evaluate the metabolic phenotypes of transgenic mouse models in which AMPK expression and function have been manipulated, and the impact this has on controlling lipid metabolism, glucose homeostasis, and inflammation. This information may be useful for guiding the development of AMPK-targeted therapeutics to treat chronic metabolic diseases.
Keywords: NAFLD; NASH; adipose tissue; atherosclerosis; beige adipose tissue; brown adipose tissue; macrophages.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Comment in
-
AMPK: An Ambiguous Position for Atrial Fibrillation.Trends Endocrinol Metab. 2018 Jun;29(6):369. doi: 10.1016/j.tem.2018.02.009. Epub 2018 Mar 21. Trends Endocrinol Metab. 2018. PMID: 29573948 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
